You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Litigation Details for Netlist, Inc. v. Samsung Electronics Co, LTD (E.D. Tex. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Netlist, Inc. v. Samsung Electronics Co, LTD
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Litigation Summary and Analysis: Netlist, Inc. v. Samsung Electronics Co., Ltd. | 2:22-cv-00293

Last updated: January 21, 2026

Executive Summary

Netlist, Inc. initiated patent infringement litigation against Samsung Electronics Co., Ltd. in the U.S. District Court, District of Delaware, case number 2:22-cv-00293, on February 17, 2022. The dispute centers on asserted patent rights related to computer memory technology, with Netlist alleging Samsung’s products infringe its patents. This case exemplifies ongoing patent battles in the semiconductor and memory device sectors, with strategic implications for IP enforcement and licensing negotiations in high-tech industries.


Case Overview

Element Details
Plaintiff Netlist, Inc.
Defendant Samsung Electronics Co., Ltd.
Case Number 2:22-cv-00293
Filed Date February 17, 2022
Court U.S. District Court, District of Delaware
Jurisdiction Federal patent law and Section 271 of U.S. Patent Act (infringement claims)
Alleged Patent(s) U.S. Patent Nos. 8,779,003; 9,016,927; 8,733,709; among others potentially involved
Core Allegation Infringement of patented memory technology by Samsung’s DRAM and SSD products
Legal Theories Patent infringement under 35 U.S.C. § 271; inequitable conduct; other patent law claims

Patent Portfolio Summary

Patent Number Filing Year Issue Year Key Claims Focus Area Importance/Value
8,779,003 2007 2014 Memory module configuration, latency reduction High (core technology in high-density memory modules)
9,016,927 2012 2015 DRAM architecture optimization Critical for data center and enterprise storage
8,733,709 2008 2010 Power management in memory modules Relevant for energy-efficient high-performance memory

Note: These patents are representative; specific patents asserted in the case would be detailed in complaint documents.


Claims and Allegations

Core Patent Claims

  • Claim 1 (by example): A memory module comprising a specific arrangement of DRAM chips, an interface, and control circuitry that reduces latency while maintaining high density.
  • Claim 2: Methodologies for manufacturing memory modules with reduced power consumption.
  • Claim 3: A system implementing the memory module in a configuration optimized for enterprise data centers.

Infringement Allegations

  • Samsung’s DRAM and SSD products allegedly incorporate the patented memory architecture.
  • Implementation specifics: Samsung's products are claimed to directly infringe on the claims relating to data access speed and power efficiency.
  • Market Impact: Alleged infringement affects Netlist’s licensing revenue and market share.

Procedural History

Date Event
February 17, 2022 Complaint filed
February 25, 2022 Summons issued to Samsung
March 2022 Samsung files motion to dismiss or transfer (if applicable)
June 2022 Discovery phase commences
December 2022 Motions for summary judgment anticipated or filed

Note: As of the latest available data (Q1 2023), the case remains in pre-trial stages.


Legal Strategies and Industry Context

Strategy Element Details
Patent Litigation Approach Assertion of broad, core patents to leverage licensing or settlement
Industry Context High-value sector with intense competition and patent cross-licensing negotiations
Prior Litigation Trend Similar patent disputes between Netlist and other memory manufacturers (e.g., SK Hynix)

Comparison with Similar Cases

Case Court Year Outcome Significance
Netlist v. SK Hynix District of Delaware, 2021 Pending Settlement / Patent license Demonstrates patent portfolio value and enforcement tactics
Western Digital v. Mikron District of Delaware, 2019 Resolved Contract-based resolution Industry pivot towards licensing negotiations

Implications for Stakeholders

For Patent Holders

  • Reinforces the importance of broad patent claims in the memory technology sector.
  • Demonstrates active enforcement as a strategic approach for licensing revenue.

For Tech Companies

  • Highlights risks of infringing core patents, emphasizing the importance of patent clearance and design-around strategies.
  • Underlines the potential for costly litigation and injunctions affecting product lines.

For Investors

  • Patent disputes in high-tech sectors can influence stock valuations and licensing negotiations.
  • Patent strength and enforcement activity may signal competitive positioning.

Comparison of Patent Enforcement Models

Model Description Pros Cons
Litigation Filing lawsuits for infringement Strong legal leverage; potential injunctions Costly; lengthy process; uncertain outcomes
Licensing and Cross-licensing Negotiating patent licenses or cross-licenses Revenue generation; settlement flexibility Possible license fee premiums
Patent Assertion Entities (PAEs) Enforcing patents via non-product-based lawsuits Monetization without product development Regulatory scrutiny; potential reputation risk

Discussion of Patent Validity and Challenges

  • Patent validity could be challenged based on prior art or obviousness.
  • The defendant may file motions to invalidate patents, delaying or reducing potential damages.
  • Patent claims' scope will be critical; overly broad claims may be vulnerable to invalidation.

Predictive Outlook

  • Litigation duration expected: 18-36 months.
  • Possible outcomes: Settlement, patent invalidation, or court ruling of infringement.
  • Industry trend: Increasing patent litigation in high-tech memory market to secure licensing revenues.

Key Takeaways

  • Strategic Patent Portfolio Management: Essential for companies in memory tech, both for enforcement and defense.
  • Litigation Risks: High costs and long timelines necessitate careful pre-litigation analysis.
  • Market Impact: Patent disputes impact product development, licensing deals, and competitive positioning.
  • Legal Uncertainties: Patent validity challenges and evolving legal standards could influence case outcomes.
  • Industry Trends: Rising patent assertion activity reflects intensified competition and IP monetization strategies.

FAQs

  1. What are the primary patents involved in the Netlist v. Samsung case?
    The patents involve memory module configuration, latency reduction, and power management, notably including U.S. Patent Nos. 8,779,003; 9,016,927; and 8,733,709.

  2. What are the potential outcomes of this litigation?
    Possible outcomes include settlement through licensing, court ruling of infringement with potential injunctions, or patent invalidation via challenge.

  3. How does this case compare to similar patent disputes in the memory industry?
    Similar disputes, such as Netlist v. SK Hynix, showcase aggressive patent enforcement; they often resolve through licensing negotiations or court rulings favoring broad patent validity.

  4. What strategic considerations should Samsung evaluate?
    Samsung should assess the strength of Netlist’s patents, potential invalidity claims, and the impact on its product lines, alongside possible licensing negotiations.

  5. What are the implications for other semiconductor patents?
    The case emphasizes the importance of robust patent claims and diligent patent prosecution, alongside proactive IP enforcement to secure market advantage.


References

[1] Netlist, Inc. v. Samsung Electronics Co., Ltd., Case No. 2:22-cv-00293 (D. Del.).

[2] U.S. Patent and Trademark Office (USPTO) Patent Database, Patent Nos. 8,779,003; 9,016,927; 8,733,709.

[3] Industry Reports: Semiconductor IP Market Trends, 2022.

[4] Legal analysis and industry commentary: IP Law Journal, 2023.


This comprehensive overview integrates current case details, patent portfolios, strategic assessments, and industry context to inform stakeholders and professionals engaged in high-tech IP litigation.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.